CA2411944A1 - The combination of antimicrobial agents and bacterial interference to coat medical devices - Google Patents
The combination of antimicrobial agents and bacterial interference to coat medical devices Download PDFInfo
- Publication number
- CA2411944A1 CA2411944A1 CA002411944A CA2411944A CA2411944A1 CA 2411944 A1 CA2411944 A1 CA 2411944A1 CA 002411944 A CA002411944 A CA 002411944A CA 2411944 A CA2411944 A CA 2411944A CA 2411944 A1 CA2411944 A1 CA 2411944A1
- Authority
- CA
- Canada
- Prior art keywords
- pathogenic
- bacterium
- coating layer
- antimicrobial agent
- bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
- A61L2300/61—Coatings having two or more layers containing two or more active agents in different layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
Abstract
This invention relates to a method for coating a medical device comprising t he steps of applying to at least a portion of the surface of said medical devic e, an antimicrobial coating layer and a non-pathogenic bacterial coating layer, wherein the antimicrobial and non-pathogenic bacterial coating layers inhibi t the growth of pathogenic bacterial and fungal organisms. The non-pathogenic bacterium used in the bacterial coating layer is resistant to the antimicrobial agent. Furthermore, the non-pathogenic bacterium layer include s at least one of the following: viable whole cells, non-viable whole cells, o r cellular structures or extracts. The antimicrobial agent and non-pathogenic bacterium are used to develop a kit comprising these compositions in one container or in separate containers. The kit is used to coat a catheter prio r to implantation in a mammal.
Claims (31)
1. A method for coating a medical device comprising the steps of:
applying to at least a portion of the surface of said medical device, an antimicrobial coating layer, wherein said antimicrobial coating layer comprises an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices; and applying to at least a portion of the surface of said medical device, a non-pathogenic bacterial coating layer, wherein said non-pathogenic bacterial coating layer comprises a non-pathogenic gram-negative bacterium in an effective concentration to inhibit the growth of pathogenic bacterial and fungal organisms, wherein said non-pathogenic gram-negative bacterium is resistant to said antimicrobial agent.
applying to at least a portion of the surface of said medical device, an antimicrobial coating layer, wherein said antimicrobial coating layer comprises an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices; and applying to at least a portion of the surface of said medical device, a non-pathogenic bacterial coating layer, wherein said non-pathogenic bacterial coating layer comprises a non-pathogenic gram-negative bacterium in an effective concentration to inhibit the growth of pathogenic bacterial and fungal organisms, wherein said non-pathogenic gram-negative bacterium is resistant to said antimicrobial agent.
2. The method of claim 1, wherein said antimicrobial agent is selected from the group consisting of an antibiotic, an antiseptic, a disinfectant and a combination thereof.
3. The method of claim 2, wherein said antimicrobial agent is selected from the group of antibiotics consisting of penicillins, cephalosporins, carbepenems, other beta-lactams antibiotics, aminoglycosides, macrolides, lincosamides, glycopeptides, tetracylines, chloramphenicol, quinolones, fucidins, sulfonamides, trimethoprims, rifamycins, oxalines, streptogramins, lipopeptides, ketolides, polyenes, azoles, and echinocandins.
4. The method of claim 2, wherein said antimicrobial agent is selected from the group of antiseptics consisting of .alpha.-terpineol, methylisothiazolone, cetylpyridinium chloride, chloroxyleneol, hexachlorophene, chlorhexidine and other cationic biguanides, methylene chloride, iodine and iodophores, triclosan, taurinamides, nitrofurantoin, methenamine, aldehydes, azylic acid, silver, benzyl peroxide, alcohols, and carboxylic acids and salts.
5. The method of claim 1, wherein said non-pathogenic gram-negative bacterium is selected from the group consisting of Enterobacteriacea, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Burkholderia cepacia, Gandnerella vaginalis, and Acinetobacter species.
6. The method of claim 5, wherein said non-pathogenic gram-negative bacterium is Pseudomonas aeruginosa.
7. The method of claim 5, wherein said non-pathogenic gram-negative bacterium is selected from the group of Enterobacteriacea consisting of Escherichia, Shigella, Edwardsiella, Salmonella, Citrobacter, Klebsiella, Enterobacter, Hafnia, Serratia, Proteus, Morganella, Providencia, Yersinia, Erwinia, Buttlauxella, Cedecea, Ewingella, Kluyvera, Tatumella and Rahnella.
8. The method of claim 7, wherein said Enterobacteriacea is Escherichia coli 83972 or mutants thereof.
9. The method of claim 1, wherein said non-pathogenic gram-negative bacterium is a bacterium which adheres to urinary catheters selected from the group consisting of Providencia, Proteus, Pseudomonas aeruginosa and Escherichia coli.
10. The method of claim 1, wherein said non-pathogenic bacterial coating layer further comprises viable whole cells of the non-pathogenic gram-negative bacterium.
11. The method of claim 1, wherein said non-pathogenic bacterial coating layer further comprises non-viable whole cells or cellular structures or extracts of the non-pathogenic gram-negative bacterium.
12. The method of claim 1, wherein said non-pathogenic bacterial coating layer further comprises at least one or more viable whole cells, non-viable whole cells or cellular structures or extracts of the non-pathogenc gram-negative bacterium.
13. The method of claim 1, wherein said non-pathogenic bacterial coating layer further comprises at least two non-pathogenic gram-negative bacteria.
14. A method for coating a medical device comprising the steps of:
applying to at least a portion of the surface of said medical device, an antimicrobial coating layer, wherein said animicrobial coating layer comprises an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices; and applying to at least a portion of the surface of said medical device, a non-pathogenic bacterial coating layer, wherein said non-pathogenic bacterial coating layer comprises non-pathogenic gram-positive bacterium in an effective concentration to inhibit the growth of pathogenic bacterial and fungal organisms, wherein said non-pathogenic gram-positive bacterium is resistant to said antimicrobial agent.
applying to at least a portion of the surface of said medical device, an antimicrobial coating layer, wherein said animicrobial coating layer comprises an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices; and applying to at least a portion of the surface of said medical device, a non-pathogenic bacterial coating layer, wherein said non-pathogenic bacterial coating layer comprises non-pathogenic gram-positive bacterium in an effective concentration to inhibit the growth of pathogenic bacterial and fungal organisms, wherein said non-pathogenic gram-positive bacterium is resistant to said antimicrobial agent.
15. The method of claim 14, wherein said non-pathogenic gram-positive bacterium is selected from the group consisting of Staphylococcus aureus, coagulase-negative staphylococci, streptococci, enterococci, corynebacteria, and Bacillus species.
16. The method of claim 14, wherein said antimicrobial agent is selected from the group of antibiotics consisting of penicillins, cephalosporins, carbepenems, other beta-lactams antibiotics, aminoglycosides, macrolides, lincosamides, glycopeptides, tetracylines, chloramphenicol, quinolones, fucidins, sulfonamides, trimethoprims, rifamycins, oxalines, streptogramins, lipopeptides, ketolides, polyenes, azoles, and echinocandins.
17. The method of claim 14, wherein said non-pathogenic bacterial coating layer further comprises viable whole cells of the non-pathogenic gram-positive bacterium.
18. The method of claim 14, wherein said non-pathogenic bacterial coating layer further comprises non-viable whole cells or cellular structures or extracts of the non-pathogenic gram-positive bacterium.
19. The method of claim 14, wherein said non-pathogenic bacterial coating layer further comprises at least one or more viable whole cells, non-viable whole cells or cellular structures or extracts of the non-pathogenic gram-positive bacterium.
20. The method of claim 14, wherein said non-pathogenic bacterial coating layer further comprises at least two non-pathogenic gram-positive bacteria.
21. The method of claim 14, wherein said non-pathogenic bacterial coating layer further comprises at least one non-pathogenic gram-positive bacterium and at least one non-pathogenic gram-negative bacterium.
22. A method for coating a medical device comprising the steps of:
applying to at least a portion of the surface of said medical device, an antimicrobial coating layer, wherein said antimicrobial coating layer comprises an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices; and applying to at least a portion of the surface of said medical device, a fungal coating layer, wherein said fungal coating layer comprises a fungus in an effective concentration to inhibit the growth of pathogenic bacterial and fungal organisms, wherein said fungus is resistant to said antimicrobial agent.
applying to at least a portion of the surface of said medical device, an antimicrobial coating layer, wherein said antimicrobial coating layer comprises an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices; and applying to at least a portion of the surface of said medical device, a fungal coating layer, wherein said fungal coating layer comprises a fungus in an effective concentration to inhibit the growth of pathogenic bacterial and fungal organisms, wherein said fungus is resistant to said antimicrobial agent.
23. The method of claim 22, wherein said fungus is Candida.
24. The method for preventing a urinary tract infection comprising the steps of:
pretreating a patient with antibiotics for five to seven days;
inoculating said patient with a culture of non-pathogenic bacterium; and applying to at least a portion of the surface of a urinary catheter, an antimicrobial coating layer having an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices.
pretreating a patient with antibiotics for five to seven days;
inoculating said patient with a culture of non-pathogenic bacterium; and applying to at least a portion of the surface of a urinary catheter, an antimicrobial coating layer having an antimicrobial agent in an effective concentration to inhibit the growth of bacterial and fungal organisms relative to uncoated medical devices.
25. A kit comprising compositions to coat the surfaces of medical devices prior to implantation into a mammal comprising an antimicrobial agent and a culture from a non-pathogenic bacterium, wherein said non-pathogenic bacterium has been genetically modified to enhance the adherence of the bacterium to the implant surface.
26. The kit of claim 25, wherein the compositions are in the same container.
27. The kit of claim 25, wherein the compositions are in different containers.
28. A kit comprising compositions to coat the surfaces of medical devices prior to implantation into a mammal comprising an antimicrobial agent and a culture from a non-pathogenic bacterium, wherein said non-pathogenic bacterium has been genetically modified to decrease the sensitivity of the bacterium to antimicrobial agents.
29. A lit comprising compositions to coat the surfaces of medical devices prior to implantation into a mammal comprising an antimicrobial agent acid a culture from a non-pathogenic bacterium, wherein said non-pathogenic bacterium has been genetically modified to increase the stability of the bacterium at room temperature.
30. A kit comprising compositions to coat the surfaces of medical devices prior to implantation into a mammal comprising an antimicrobial agent and a culture from a non-pathogenic bacterium, wherein said non-pathogenic bacterium has been lyophilized and reconstituted prior to application to the surface of the implant.
31. A lit comprising a medical device pre-coated with an antimicrobial agent and compositions to coat said medical device prior to implantation into a mammal comprising a culture from a non-pathogenic bacterium.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21071500P | 2000-06-09 | 2000-06-09 | |
US60/210.715 | 2000-06-09 | ||
PCT/US2001/018596 WO2001095876A1 (en) | 2000-06-09 | 2001-06-08 | The combination of antimicrobial agents and bacterial interference to coat medical devices |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2411944A1 true CA2411944A1 (en) | 2001-12-20 |
CA2411944C CA2411944C (en) | 2010-12-14 |
Family
ID=22783988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2411944A Expired - Fee Related CA2411944C (en) | 2000-06-09 | 2001-06-08 | The combination of antimicrobial agents and bacterial interference to coat medical devices |
Country Status (7)
Country | Link |
---|---|
US (3) | US6719991B2 (en) |
EP (1) | EP1303256B1 (en) |
AT (1) | ATE419880T1 (en) |
AU (1) | AU2001271292A1 (en) |
CA (1) | CA2411944C (en) |
DE (1) | DE60137334D1 (en) |
WO (1) | WO2001095876A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921365B2 (en) | 2007-07-23 | 2014-12-30 | Biomet Deutschland Gmbh | Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060025726A1 (en) * | 1996-06-04 | 2006-02-02 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Implantable medical device with pharmacologically active layer |
US20060030826A1 (en) * | 1996-06-04 | 2006-02-09 | Vance Products Incorporated,d/b/a Cook Urological Incorporated | Implantable medical device with anti-neoplastic drug |
US20060052757A1 (en) * | 1996-06-04 | 2006-03-09 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Implantable medical device with analgesic or anesthetic |
ATE419880T1 (en) * | 2000-06-09 | 2009-01-15 | Baylor College Medicine | COMBINATION OF ANTIMICROBIAL ACTIVES AND BACTERIAL INTERFERENCE FOR COATING MEDICAL DEVICES |
US6692480B1 (en) * | 2000-10-27 | 2004-02-17 | Irving M. Bush | Method and apparatus for treating and preventing urinary tract infections |
US7329412B2 (en) * | 2000-12-22 | 2008-02-12 | The Trustees Of Columbia University In The City Of New York | Antimicrobial medical devices containing chlorhexidine free base and salt |
WO2002072031A2 (en) * | 2001-03-14 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as synergistic antifungal agents |
US6589591B1 (en) * | 2001-07-10 | 2003-07-08 | Baylor College Of Medicine | Method for treating medical devices using glycerol and an antimicrobial agent |
AU2002320456A1 (en) * | 2001-07-26 | 2003-02-17 | Alveolus Inc. | Removable stent and method of using the same |
EP1458390B1 (en) * | 2001-11-30 | 2008-08-13 | LG Life Sciences Ltd. | A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent |
WO2003061715A1 (en) * | 2002-01-22 | 2003-07-31 | Pharmacia & Upjohn Company | Infection-resistant medical devices |
US20050192547A1 (en) * | 2002-01-31 | 2005-09-01 | Modak Shanta M. | Combinations of antiseptic and antibiotic agents containing medical devices |
US6887270B2 (en) * | 2002-02-08 | 2005-05-03 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
US8685427B2 (en) * | 2002-07-31 | 2014-04-01 | Boston Scientific Scimed, Inc. | Controlled drug delivery |
US8133501B2 (en) | 2002-02-08 | 2012-03-13 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled drug delivery |
US7993390B2 (en) | 2002-02-08 | 2011-08-09 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
US8920826B2 (en) * | 2002-07-31 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical imaging reference devices |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7959671B2 (en) * | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US7527644B2 (en) * | 2002-11-05 | 2009-05-05 | Alveolus Inc. | Stent with geometry determinated functionality and method of making the same |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US20040115477A1 (en) * | 2002-12-12 | 2004-06-17 | Bruce Nesbitt | Coating reinforcing underlayment and method of manufacturing same |
DK1599248T3 (en) | 2003-02-26 | 2010-10-11 | Coloplast As | Medical device with a coating comprising hydrogen peroxide and package therefor |
US7488757B2 (en) * | 2003-03-24 | 2009-02-10 | Becton, Dickinson And Company | Invisible antimicrobial glove and hand antiseptic |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
JP2006528704A (en) * | 2003-05-27 | 2006-12-21 | セラヴァンス インコーポレーテッド | Use of polyene macrolide antifungal agents in combination with glycopeptide antibacterial agents |
US7452861B2 (en) * | 2003-07-22 | 2008-11-18 | Theravance, Inc. | Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
WO2005037338A1 (en) * | 2003-10-14 | 2005-04-28 | Cook Incorporated | Hydrophilic coated medical device |
DE10352578B3 (en) * | 2003-11-11 | 2005-03-24 | Leica Microsystems Nussloch Gmbh | Microtome includes manually operated sample holder, cutting unit, section receiver and cut section interception pan having coating with silver ion release system |
DE10352575B3 (en) * | 2003-11-11 | 2005-05-04 | Leica Microsystems Nussloch Gmbh | Cryostat with an inner container for receiving a microtome |
WO2005052366A2 (en) | 2003-11-20 | 2005-06-09 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Portable hand pump for evacuation of fluids |
DE102004011293A1 (en) * | 2004-03-09 | 2005-09-22 | Aesculap Ag & Co. Kg | Medical products for internal or external (e.g. wound enclosure) applications have polyhexamethylene biguanide (PHMB) as a non-specific antimicrobial component in the surface zone |
CA2561496A1 (en) * | 2004-04-02 | 2005-10-20 | Baylor College Of Medicine | Novel modification of medical prostheses |
US8337475B2 (en) | 2004-10-12 | 2012-12-25 | C. R. Bard, Inc. | Corporeal drainage system |
WO2006063176A2 (en) * | 2004-12-06 | 2006-06-15 | The Government Of The Usa As Representedtd By The Secretary Of The Dept Of Health And Human Services | Inhibition of biofilm formation using bacteriophage |
US8083805B2 (en) * | 2005-08-16 | 2011-12-27 | Poly-Med, Inc. | Absorbable endo-urological devices and applications therefor |
US8083806B2 (en) * | 2005-02-04 | 2011-12-27 | Poly-Med, Inc. | Radiation and radiochemically sterilized fiber-reinforced, composite urinogenital stents |
CA2596885C (en) * | 2005-02-04 | 2014-07-08 | Poly-Med, Inc. | Fiber-reinforced composite absorbable endoureteral stent |
US20050267447A1 (en) * | 2005-04-25 | 2005-12-01 | Harrison Nora T | Harrison improved female self-catheter |
WO2007038643A1 (en) | 2005-09-26 | 2007-04-05 | C.R. Bard, Inc. | Catheter connection systems |
US20070093894A1 (en) * | 2005-10-25 | 2007-04-26 | Baylor College Of Medicine | Incorporation of antimicrobial combinations onto devices to reduce infection |
US20070166409A1 (en) * | 2006-01-17 | 2007-07-19 | Royds Robert B | Therapeutic compositions containing trimethoprim and cranberry extract and methods for treating and preventing urinary tract infections |
US8591531B2 (en) | 2006-02-08 | 2013-11-26 | Tyrx, Inc. | Mesh pouches for implantable medical devices |
EP2114298B1 (en) | 2006-02-08 | 2022-10-19 | Medtronic, Inc. | Temporarily stiffened mesh prostheses |
US20070224288A1 (en) * | 2006-03-22 | 2007-09-27 | Kiss Nail Products, Inc. | Antibacterial gel coating and pedicure spa with antibacterial function |
US20080033371A1 (en) * | 2006-06-26 | 2008-02-07 | Updegraff Debra K | Cover for catheter assembly |
US8512294B2 (en) * | 2006-07-28 | 2013-08-20 | Becton, Dickinson And Company | Vascular access device antimicrobial materials and solutions |
US9023114B2 (en) * | 2006-11-06 | 2015-05-05 | Tyrx, Inc. | Resorbable pouches for implantable medical devices |
EP2134409A4 (en) * | 2007-03-09 | 2013-07-17 | Anthem Orthopaedics Llc | Implantable medicament delivery device and delivery tool and method for use therewith |
EP2155277A2 (en) | 2007-05-01 | 2010-02-24 | Oplon B.V. | Biocidic medical devices, implants and wound dressings |
US9981069B2 (en) | 2007-06-20 | 2018-05-29 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
US20090041727A1 (en) * | 2007-08-08 | 2009-02-12 | Conjugon, Inc. | Compositions and Methods for Microbe Storage and Delivery |
US20090099531A1 (en) * | 2007-10-15 | 2009-04-16 | Griesbach Iii Henry Louis | Packaging for selectivity lubricating part of a medical device |
CN102112139A (en) | 2007-10-30 | 2011-06-29 | 乌第有限合伙公司 | Method and system for sustained-release of sclerosing agent |
US20090261001A1 (en) * | 2008-04-18 | 2009-10-22 | Medline Industries, Inc. | Glove packaging having antimicrobial barrier |
US9139355B2 (en) | 2008-04-18 | 2015-09-22 | Medline Industries, Inc. | Glove packaging having antimicrobial barrier |
DE102008026207B4 (en) * | 2008-05-30 | 2015-01-15 | Manouchehr Abdolali | Coating agent for coating a surface of a medical implant |
CN102123693A (en) | 2008-06-13 | 2011-07-13 | 奥洁克公司 | Use of hydrogen peroxide-producing bacteria for tooth whitening |
US8076529B2 (en) | 2008-09-26 | 2011-12-13 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix for intraluminal drug delivery |
US8049061B2 (en) | 2008-09-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery |
US8500687B2 (en) | 2008-09-25 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Stent delivery system having a fibrous matrix covering with improved stent retention |
US8226603B2 (en) | 2008-09-25 | 2012-07-24 | Abbott Cardiovascular Systems Inc. | Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery |
US8821455B2 (en) * | 2009-07-09 | 2014-09-02 | Becton, Dickinson And Company | Antimicrobial coating for dermally invasive devices |
US10265435B2 (en) | 2009-08-27 | 2019-04-23 | Silver Bullet Therapeutics, Inc. | Bone implant and systems and coatings for the controllable release of antimicrobial metal ions |
US8221396B2 (en) | 2009-08-27 | 2012-07-17 | Silver Bullet Therapeutics, Inc. | Bone implants for the treatment of infection |
US9114197B1 (en) | 2014-06-11 | 2015-08-25 | Silver Bullett Therapeutics, Inc. | Coatings for the controllable release of antimicrobial metal ions |
US9821094B2 (en) | 2014-06-11 | 2017-11-21 | Silver Bullet Therapeutics, Inc. | Coatings for the controllable release of antimicrobial metal ions |
US8927004B1 (en) | 2014-06-11 | 2015-01-06 | Silver Bullet Therapeutics, Inc. | Bioabsorbable substrates and systems that controllably release antimicrobial metal ions |
US20110065798A1 (en) * | 2009-09-17 | 2011-03-17 | Becton, Dickinson And Company | Anti-infective lubricant for medical devices and methods for preparing the same |
US20110076312A1 (en) * | 2009-09-29 | 2011-03-31 | Ethicon, Inc. | Antimicrobial/antibacterial medical devices coated with traditional chinese medicines |
WO2012109263A1 (en) | 2011-02-07 | 2012-08-16 | The Washington University | Mannoside compounds and methods of use thereof |
US8808724B2 (en) | 2009-10-28 | 2014-08-19 | Ethicon, Inc. | Antimicrobial coatings with preferred microstructure for medical devices |
WO2011085367A2 (en) * | 2010-01-11 | 2011-07-14 | Oragenics, Inc. | Non-replicating microorganisms as post-biotics |
WO2012013577A1 (en) | 2010-07-26 | 2012-02-02 | Laboratorios Miret, S.A. | Composition for coating medical devices containing lae and a polycationic amphoteric polymer |
WO2012064402A1 (en) | 2010-11-12 | 2012-05-18 | Silver Bullet Therapeutics, Inc. | Bone implant and systems that controllably releases silver |
WO2012137164A1 (en) | 2011-04-07 | 2012-10-11 | Biolinerx Ltd. | Antimicrobial compositions, antibiofilm compositions and uses thereof |
WO2012137166A1 (en) | 2011-04-07 | 2012-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | An oxoborolidine compound and uses thereof |
US8758013B2 (en) * | 2011-05-17 | 2014-06-24 | Zimmer Dental, Inc. | Prosthetic apparatus |
EP2744433B1 (en) * | 2011-08-18 | 2016-03-30 | Matthias Militz | Medical device for bone expansion |
EA030573B1 (en) | 2013-01-02 | 2018-08-31 | Дикой Байосистемз, Инк. | Compositions and methods for treatment of cancer using bacteria |
US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US9695323B2 (en) | 2013-02-13 | 2017-07-04 | Becton, Dickinson And Company | UV curable solventless antimicrobial compositions |
US9750927B2 (en) | 2013-03-11 | 2017-09-05 | Becton, Dickinson And Company | Blood control catheter with antimicrobial needle lube |
US9327095B2 (en) | 2013-03-11 | 2016-05-03 | Becton, Dickinson And Company | Blood control catheter with antimicrobial needle lube |
US10085716B2 (en) | 2013-03-15 | 2018-10-02 | J. Jordan Romano | System and method for sterile sheathing of a medical probe |
CA2913622A1 (en) | 2013-05-30 | 2014-12-04 | Washington University | Compounds and methods for treating bacterial infections |
WO2015027159A1 (en) | 2013-08-23 | 2015-02-26 | University Of Houston | Non-pathogenic biofilms and uses thereof |
US9675793B2 (en) | 2014-04-23 | 2017-06-13 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
US9789279B2 (en) | 2014-04-23 | 2017-10-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
US9452242B2 (en) | 2014-06-11 | 2016-09-27 | Silver Bullet Therapeutics, Inc. | Enhancement of antimicrobial silver, silver coatings, or silver platings |
US10232088B2 (en) | 2014-07-08 | 2019-03-19 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
WO2016159859A1 (en) * | 2015-03-27 | 2016-10-06 | Stenutz Roland | Mannan oligosaccharides for the treatment of urinary tract infection |
US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
US10738070B2 (en) | 2016-03-23 | 2020-08-11 | Fimbrion Therapeutics, Inc. | Mannose-derived antagonists of FimH useful for treating disease |
EP3484559B1 (en) | 2016-07-18 | 2023-08-23 | Merit Medical Systems, Inc. | Inflatable radial artery compression device |
IL258467A (en) | 2018-03-29 | 2018-07-04 | Ilana Kolodkin Gal | Methods of disrupting a biofilm and/or preventing formation of same |
LT3820856T (en) | 2018-07-10 | 2022-11-10 | Glaxosmithkline Intellectual Property Development Limited | C-mannoside compopunds useful for the treatment of urinary tract infections |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US31601A (en) * | 1861-03-05 | Improvement in sewing-machines | ||
US120333A (en) * | 1871-10-24 | Improvement in medical compounds for purifying the blood | ||
US98278A (en) * | 1869-12-28 | Improvement in metallic cartridges | ||
FR1185M (en) * | 1961-03-03 | 1962-03-19 | Ile De Rech S Scient Et Ind So | Medicinal product based on live non-pathogenic colibacilli. |
US4442133A (en) | 1982-02-22 | 1984-04-10 | Greco Ralph S | Antibiotic bonding of vascular prostheses and other implants |
US5804179A (en) | 1985-12-31 | 1998-09-08 | Research Corporation Technologies, Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
US4846844A (en) * | 1987-08-31 | 1989-07-11 | Eli Lilly And Company | Antimicrobial coated implants |
US5019096A (en) | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
US5089205A (en) * | 1989-09-25 | 1992-02-18 | Becton, Dickinson And Company | Process for producing medical devices having antimicrobial properties |
US5344411A (en) * | 1991-02-27 | 1994-09-06 | Leonard Bloom | Method and device for inhibiting HIV, hepatitis B and other viruses and germs when using a catheter in a medical environment |
FR2679142B1 (en) * | 1991-07-18 | 1995-06-09 | Nice Sophia Antipolis Universi | PROCESS FOR THE PROTECTION OF PROSTHESES, IMPLANTABLE PROVISIONAL OR DEFINITIVE MATERIALS AGAINST COLONIZATION AND BACTERIAL INFECTION. |
GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
CA2125167A1 (en) * | 1991-12-06 | 1993-06-10 | North Shore University Hospital Research Corporation | Method of reducing medical device related infections |
US5217493A (en) * | 1992-03-11 | 1993-06-08 | Board Of Regents, The University Of Texas System | Antibacterial coated medical implants |
DK0760848T3 (en) | 1994-05-26 | 1998-09-23 | Bracco Spa | Lactobacillus strains of human origin, their compositions and their use |
US6468649B1 (en) * | 1995-02-22 | 2002-10-22 | Scimed Life Systems, Inc. | Antimicrobial adhesion surface |
US5624704A (en) | 1995-04-24 | 1997-04-29 | Baylor College Of Medicine | Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent |
US5756145A (en) | 1995-11-08 | 1998-05-26 | Baylor College Of Medicine | Durable, Resilient and effective antimicrobial coating for medical devices and method of coating therefor |
US6558686B1 (en) * | 1995-11-08 | 2003-05-06 | Baylor College Of Medicine | Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor |
US6143037A (en) * | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
JPH10328293A (en) * | 1997-06-04 | 1998-12-15 | Unitika Ltd | Medical instrument and manufacture therefor |
US6099853A (en) * | 1997-09-04 | 2000-08-08 | Protein Express | Vaginal suppository vaccine for urogenital infections |
US6365220B1 (en) * | 1997-11-03 | 2002-04-02 | Nucryst Pharmaceuticals Corp. | Process for production of actively sterile surfaces |
US6344201B1 (en) * | 1998-03-31 | 2002-02-05 | Anthony T. Maurelli | Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections |
US6166007A (en) * | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
IL142129A0 (en) | 1998-09-23 | 2002-03-10 | Phycogen Inc | Antifouling agents |
US6296863B1 (en) * | 1998-11-23 | 2001-10-02 | Agion Technologies, Llc | Antimicrobial fabric and medical graft of the fabric |
AU2042200A (en) * | 1998-12-07 | 2000-06-26 | Baylor College Of Medicine | Preventing and removing biofilm from the surface of medical devices |
US6475435B1 (en) * | 1999-02-02 | 2002-11-05 | Steuben Foods Incorporated | Apparatus and method for providing sterilization zones in an aseptic packaging sterilization tunnel |
IL131623A0 (en) * | 1999-08-27 | 2001-01-28 | Dan Weiss | Apparatus to couple ultrasonic energy to catheters and other transdermal medical devices |
US6368611B1 (en) * | 1999-08-31 | 2002-04-09 | Sts Biopolymers, Inc. | Anti-infective covering for percutaneous and vascular access device and coating method |
DE60027472T2 (en) * | 1999-12-20 | 2006-12-07 | Et Agroalimentaire Canada, Lennoxville | METHOD AND COMPOSITION FOR TREATMENT AND / OR PROPHYLAXIS OF ANTIBIOTICUM RESISTANT MICROORGANISM INFECTIONS |
ATE419880T1 (en) | 2000-06-09 | 2009-01-15 | Baylor College Medicine | COMBINATION OF ANTIMICROBIAL ACTIVES AND BACTERIAL INTERFERENCE FOR COATING MEDICAL DEVICES |
US6918927B2 (en) * | 2000-10-31 | 2005-07-19 | Cook Incorporated | Coated implantable medical device |
US20020120333A1 (en) * | 2001-01-31 | 2002-08-29 | Keogh James R. | Method for coating medical device surfaces |
US6589591B1 (en) * | 2001-07-10 | 2003-07-08 | Baylor College Of Medicine | Method for treating medical devices using glycerol and an antimicrobial agent |
US7238669B2 (en) * | 2002-09-11 | 2007-07-03 | The Curators Of The University Of Missouri | Phage-display peptides as novel antimicrobial agents against Haemophilus influenzae |
US7314857B2 (en) * | 2003-08-25 | 2008-01-01 | Kane Biotech Inc. | Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
US7144992B2 (en) * | 2004-04-01 | 2006-12-05 | Kane Biotech Inc. | Synergistic antimicrobial compositions and methods for reducing biofilm formation |
CA2561496A1 (en) * | 2004-04-02 | 2005-10-20 | Baylor College Of Medicine | Novel modification of medical prostheses |
GB0410749D0 (en) * | 2004-05-14 | 2004-06-16 | Dow Corning Ireland Ltd | Coating apparatus |
WO2006031943A1 (en) * | 2004-09-14 | 2006-03-23 | Eldridge Gary R | Compounds, compositions and methods for controlling biofilms and bacterial infections |
BRPI0608690B8 (en) * | 2005-03-10 | 2021-05-25 | 3M Innovative Properties Co | use of an antimicrobial composition |
US20070093894A1 (en) * | 2005-10-25 | 2007-04-26 | Baylor College Of Medicine | Incorporation of antimicrobial combinations onto devices to reduce infection |
EP1987106A2 (en) * | 2006-02-23 | 2008-11-05 | E.I. Du Pont De Nemours And Company | Removable antimicrobial coating compositions and methods of use |
WO2007100881A2 (en) * | 2006-02-28 | 2007-09-07 | Tyco Healthcare Group Lp | Antimicrobial medical devices |
US20090016990A1 (en) * | 2007-01-24 | 2009-01-15 | Alberte Randall S | Antimicrobial Compositions |
US20090041727A1 (en) * | 2007-08-08 | 2009-02-12 | Conjugon, Inc. | Compositions and Methods for Microbe Storage and Delivery |
-
2001
- 2001-06-08 AT AT01950281T patent/ATE419880T1/en not_active IP Right Cessation
- 2001-06-08 EP EP01950281A patent/EP1303256B1/en not_active Expired - Lifetime
- 2001-06-08 WO PCT/US2001/018596 patent/WO2001095876A1/en active Application Filing
- 2001-06-08 DE DE60137334T patent/DE60137334D1/en not_active Expired - Lifetime
- 2001-06-08 US US09/877,898 patent/US6719991B2/en not_active Expired - Lifetime
- 2001-06-08 CA CA2411944A patent/CA2411944C/en not_active Expired - Fee Related
- 2001-07-08 AU AU2001271292A patent/AU2001271292A1/en not_active Abandoned
-
2004
- 2004-02-26 US US10/788,060 patent/US7790183B2/en not_active Expired - Fee Related
- 2004-02-26 US US10/787,627 patent/US20040166102A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921365B2 (en) | 2007-07-23 | 2014-12-30 | Biomet Deutschland Gmbh | Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
US9968710B2 (en) | 2007-07-23 | 2018-05-15 | Biomet Deutschland Gmbh | Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
CA2411944C (en) | 2010-12-14 |
US20020031601A1 (en) | 2002-03-14 |
AU2001271292A1 (en) | 2001-12-24 |
EP1303256A4 (en) | 2004-04-07 |
US6719991B2 (en) | 2004-04-13 |
US7790183B2 (en) | 2010-09-07 |
US20040166094A1 (en) | 2004-08-26 |
DE60137334D1 (en) | 2009-02-26 |
EP1303256A1 (en) | 2003-04-23 |
US20040166102A1 (en) | 2004-08-26 |
ATE419880T1 (en) | 2009-01-15 |
EP1303256B1 (en) | 2009-01-07 |
WO2001095876A1 (en) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2411944A1 (en) | The combination of antimicrobial agents and bacterial interference to coat medical devices | |
AU2006265707B2 (en) | Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices | |
EP0830107B1 (en) | Antimicrobial impregnated catheters and medical implants and method for impregnating the same | |
Cirioni et al. | RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter—associated Staphylococcus aureus infections | |
Raad et al. | Antibiotics and prevention of microbial colonization of catheters | |
US7713472B2 (en) | Antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces | |
US5756145A (en) | Durable, Resilient and effective antimicrobial coating for medical devices and method of coating therefor | |
US7144992B2 (en) | Synergistic antimicrobial compositions and methods for reducing biofilm formation | |
US6468649B1 (en) | Antimicrobial adhesion surface | |
US20060018945A1 (en) | Gallium inhibits biofilm formation | |
Černohorská et al. | Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa | |
US20070009566A1 (en) | Method and apparatus for treating bacterial infections in devices | |
Loertzer et al. | Use of catheters with the AgION antimicrobial system in kidney transplant recipients to reduce infection risk | |
Darouiche et al. | In vitro activity and in vivo efficacy of antimicrobial-coated vascular grafts | |
Zheliba et al. | Assessment of the antimicrobial activity of polymer materials with added nanosilica modified by silver compounds | |
Greene | Infections related to vascular access devices | |
YAMAZOE et al. | Antimicrobial Activity of Acrinol and Pyoktanin against Methicillin-resistant Staphylococcus aureus | |
TSHIKANTWA et al. | Biofilm formation Inhibition Strategy: Recent Developments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20180608 |